Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Shenzhen Kangtai Biological Products (300601.SZ)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (Rmb)	Price Target (Rmb)	Rating
2022-03-30	57.69	78.125	Buy
2022-05-05	40.80	72.50	Buy
2022-08-19	35.23	66.00	Buy
2022-10-31	31.12	60.00	Buy
2023-04-26	30.15	55.00	Buy
2023-08-28	27.49	49.60	Buy
2023-10-27	29.18	46.00	Buy
2024-05-06	21.25	41.50	Buy
2024-06-06	17.45	37.40	Buy
2024-07-24	14.67	16.00	Neutral
2024-09-06	13.61	15.00	Neutral
2024-11-13	20.45	21.90	Neutral
2025-03-18	16.50	-	No Rating
2025-05-21	14.32	14.30	Neutral

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.